Although CD9 seems to be associated with unfavorable outcome and disease progression in acute lymphoblastic leukemia (ALL), this marker has not yet been studied in acute myeloid leukemia (AML). The gene discussed is CD9; the disease is acute lymphoblastic leukemia.